Molecular Detection of Human parvovirus B19 in Patients with Thalassemia in Wasit Province, Iraq
Keywords:
Human parvovirus 19, Thalassemia, PCR. WasitAbstract
Human B19 (PVB19) isssmall, non-envelope single strand DNA viruses from family of "Parvoviridae" it cause infections in human. In thalassemia are a heterogeneous grouping of genetic disorders that result from a decreased synthesis of alpha or beta chains of hemoglobin (Hb). Numerous factors contributes to functional abnormality found in βeta thalassemia patient like decrease red cells life span, rapidsiron turnover, and tissue deposition of excess iron B19 targets the erythroid progenitors in the bone marrow by binding to the glycosphingolipid. This case cross sectional study and the patients aged between (5-40) years , study has been carried outsin Al-Kut teaching hospitals in Al-Iraq-Wasit in a period between September 2023 and March 2024. This study followed the cross sectional design. The populations of our study included 120 patients samples with thalassemia infected by Human Parvovirus B19 in blood transfusion patients 64 male and 56 female. Nested-PCR used to detect of B19V by using primers. PCR reaction was done by using special sets of primers mentioned previously and special components and specific program and procedure according to components of PCR reaction. Human parvovirus 19 Positive case percentage using polymerase chain reaction indicated that the positive cases was reported according to polymerase chain reaction (PCR) as a percentage of case related to the main characteristic of patients, current study data has been indicated as following: in total of 120 patient sample with thalassemia has been included in this study, PCR positive case was 17 (14.2%), 6 (5%), 2 (1.7%) and 0 (0%) in the age groups (5-15), (16-25), (26-35) and (36-45) respectively. Male was more prevalent 17 (14.2%), than female 8 (6.7%), So as to records of major type in comparision to intermediate 19 (15.8%) and 6 (5%). All positive cases were 25 cases. Current data showed prevalence of Human parvovirus 19 in Iraqi patients. This prevalence should be alarming public health.
References
Zakrzewska K, Arvia R, Bua G, Margheri F, Gallinella G. Parvovirus B19: Insights and implication for pathogenesis, prevention and therapy. Aspects of Molecular Medicine. 2023:100007.
Yu MyW, Alter HJ, Virata‐Theimer MLA, Geng Y, Ma L, Schechterly CA, et al. Parvovirus B19 infection transmitted by transfusion of red blood cells confirmed by molecular analysis of linked donor and recipient samples. Transfusion. 2010;50(8):1712-21.
Ning K, Zou W, Xu P, Cheng F, Zhang EY, Zhang-Chen A, et al. Identification of AXL as a co-receptor for human parvovirus B19 infection of human erythroid progenitors. Science advances. 2023;9(2):eade0869.
Serjeant G, Goldstein A. B19 virus infection and the aplastic crisis. Parvoviruses and human disease: CRC Press; 2018. p. 85-92.
Helmi N, Bashir M, Shireen A, Ahmed IM. Thalassemia review: features, dental considerations and management. Electronic physician. 2017;9(3):4003.
Jalil T, Yousafzai YM, Rashid I, Ahmed S, Ali A, Fatima S, et al. Mutational analysis of beta thalassaemia by multiplex ARMS-PCR in Khyber Pakhtunkhwa, Pakistan. Journal of Ayub Medical College Abbottabad. 2019;31(1):98-103.
Ponticelli C, Musallam KM, Cianciulli P, Cappellini MD. Renal complications in transfusion-dependent beta thalassaemia. Blood reviews. 2010;24(6):239-44.
Yousuf A. Human parvovirus B19 sero-molecular prevalence in Madinah blood donors, Saudi Arabia. Medical Science. 2022;25(113):1551-7.
Xu M, Leskinen K, Gritti T, Groma V, Arola J, Lepistö A, et al. Prevalence, cell tropism, and clinical impact of human parvovirus persistence in adenomatous, cancerous, inflamed, and healthy intestinal mucosa. Frontiers in Microbiology. 2022;13:914181.
Nikoozad R, Mahzounieh MR, Ghorani MR. Detection of parvovirus B19 infection in thalasemic patients in Isfahan province, Iran. Jundishapur journal of microbiology. 2015;8(11).
Heegaard ED, Jensen IP, Christensen J. Novel PCR assay for differential detection and screening of erythrovirus B19 and erythrovirus V9. Journal of medical virology. 2001;65(2):362-7.
Parmigiani SV, Barini R, Costa SCB, Amaral E, Silva JCGd, Pinto e Silva JLdC. Accuracy of the serological ELISA test compared with the polymerase chain reaction for the diagnosis of cytomegalovirus infection in pregnancy. Sao Paulo Medical Journal. 2003;121:97-101.
Reed MR, Gilliam BE, Syed RH, Moore TL. Rheumatic manifestations of parvovirus B19 in children. Journal of Pediatric Infectious Diseases. 2009;4(04):333-42.
Sevall JS, Ritenhous J, Peter J. Laboratory diagnosis of parvovirus B19 infection. Journal of clinical laboratory analysis. 1992;6(4):171-5.
Rogo L, Mokhtari-Azad T, Kabir M, Rezaei F. Human parvovirus B19: a review. Acta Virol. 2014;58(3):199-213.
Kishore J, Srivastava M, Choudhury N. Serological study on parvovirus B19 infection in multitransfused thalassemia major patients and its transmission through donor units. Asian journal of transfusion science. 2011;5(2):140-3.
Grabarczyk P, Kalińska A, Kara M, Wieczorek R, Ejduk A, Sulkowska E, et al. Identification and characterization of acute infection with parvovirus B19 genotype 2 in immunocompromised patients in Poland. Journal of medical virology. 2011;83(1):142-9.
Rinckel LA, Buno BR, Gierman TM, Lee DC. Discovery and analysis of a novel parvovirus B19 genotype 3 isolate in the United States. Transfusion. 2009;49(7):1488-92.
Slavov SN, Haddad SK, Silva‐Pinto AC, Amarilla AA, Alfonso HL, Aquino VH, et al. Molecular and phylogenetic analyses of human Parvovirus B19 isolated from Brazilian patients with sickle cell disease and β‐thalassemia major and healthy blood donors. Journal of Medical Virology. 2012;84(10):1652-65.
Fanos HK, Mohammed AH. Human Parvovirus B19 In Patients with Beta Thalassemia major: A Case Study. Biochemical and Cellular Archives. 2021;21(1):1371-5.
Arabzadeh SAM, Alizadeh F, Tavakoli A, Mollaei H, Bokharaei-Salim F, Karimi G, et al. Human parvovirus B19 in patients with beta thalassemia major from Tehran, Iran. Blood research. 2017;52(1):50-4.
Majeed HM. Detection of Parvovirus B19 Infection in Thalasemic Patients in Tikrit City, Serological Study. Medico-legal Update. 2020;20(1).
